Paul L Berns

10% owner, Lyell Immunopharma, Inc.; See Remarks, Director, Neumora Therapeutics, Inc.

Bought, 12 months

$12.5M

Sold, 12 months

$0.0M

Companies

Latest trade

Mar 6, 2026

Companies

Lyell Immunopharma, Inc.10% owner +$12.5M Neumora Therapeutics, Inc.See Remarks, Director −$0.0M

Trades

LYEL Bought 488,090 shares at $25.61 $12.5M Mar 6

NMRA Sold 9,819 shares at $3.51 $0.0M Feb 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.